Bright Therapeutics
Bright Therapeutics operates a multi-diagnostic digital therapeutics platform delivering condition-specific apps (Recovery Record, MoodLinks, Recovery Path, Nourishly) that extend evidence-based mental health and behavioral care between therapy sessions for 30,000+ clinicians, 1,000+ clinical groups, and enterprise health plans.
- Company typePrivate
- Founded-
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Bright Therapeutics does
Bright Therapeutics (legal entity Recovery Record, Inc.) is a San Francisco-based digital therapeutics company that operates a multi-diagnostic platform of condition-specific mobile applications extending evidence-based mental health care between therapy sessions. Its core products include Recovery Record for eating disorders, MoodLinks for mood and anxiety disorders, Recovery Path for substance use disorders, and Nourishly with specialized variants for diabetes management and IBS/FODMAP tracking. The apps deliver structured daily check-ins, guided therapeutic tasks, and session-ready clinical data summaries aligned with CBT, DBT, and ACT modalities; enterprise clients additionally receive bespoke EMR integrations. The platform serves over 30,000 clinicians across 1,000+ clinical groups including NHS, Kaiser Permanente, Mass General, UNC Health, and UC San Diego Health, reaching 2.5M+ clients and producing peer-reviewed evidence in journals such as JMIR Mental Health and the International Journal of Eating Disorders.
Bright operates a multi-channel go-to-market combining a self-serve freemium tier for individual clinicians (free first patient, then monthly/annual subscriptions), inside sales for group accounts of 5+ clinicians with month-to-month terms, and enterprise field sales targeting large health systems and national health plans. Revenue streams include individual clinician subscriptions, group/corporate team subscriptions, enterprise health plan contracts priced on participation-based case rates, and white-labeled/licensed enterprise branded solutions with custom EMR integrations. The company maintains a science-led marketing approach anchored in academic partnerships with Duke, Stanford, UNC, TUM, Nova Scotia Health, and Kaiser Permanente, with Dr. Jorge Palacios serving as Chief Science Officer and Jenna Tregarthen as co-founder and CEO.
Bright is described as profitable and self-funded, with all 50 US states represented through health plan coverage benefits. Quantitative outcomes cited from peer-reviewed sources include 9 additional outpatient sessions per client over 6 months, a 3.8x reduction in ER admissions, 4x more client communication relative to phone outreach, and 89% clinician and member satisfaction on efficiency and deterioration prevention metrics.
Bright Therapeutics firmographics
Firmographics- Name
- Bright Therapeutics
- Legal name
- Recovery Record, Inc.
- Website
- https://brighttherapeutics.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Bright Therapeutics operates a multi-diagnostic digital therapeutics platform delivering condition-specific apps (Recovery Record, MoodLinks, Recovery Path, Nourishly) that extend evidence-based mental health and behavioral care between therapy sessions for 30,000+ clinicians, 1,000+ clinical groups, and enterprise health plans.
- Ownership category
- akta.pro rank
Bright Therapeutics industry classification
Industry- Product category
- Digital Therapeutics / Behavioral Health Software
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (62142), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Behavioral Health & Substance Use Remote Monitoring (HLACAFAD), Eating Disorder Treatment Programs (HLAFACAK), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where Bright Therapeutics is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bright Therapeutics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Individual Clinician Subscriptions: Individual clinicians and small teams subscribe to monthly or annual plans to access Bright's apps as part of their clinical practice. First patient is free; paid plans unlock unlimited patient links and full feature access.
- Group/Corporate Accounts: Groups of 5+ clinicians subscribe to team accounts with unlimited patient links, account management, outcome tracking and reporting, training, onboarding support, and group discounts.
- Enterprise Health Plan Contracts: Enterprise health plans contract Bright for coverage of their members. Pricing is based on meaningful participation rather than PMPM or enrollment-only metrics, with affordability at scale.
- Enterprise Branded Solutions: Large enterprise organizations receive white-labeled or custom-branded solutions with custom features and EMR integrations, including bespoke integration with medical records and reporting systems.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free single-patient account for individual clinicians to evaluate the platform |
| Subscription | Monthly | Monthly or annual subscription plans for individual clinicians using Bright regularly |
| Subscription | Monthly | Team account for 5+ clinicians with unlimited patient links and group management tools |
| Subscription | Multi-year contract | Custom enterprise agreements for health plans and large health systems |
Go-to-market motion4 records
Distribution channels4 records
Marketing channels4 records
Bright Therapeutics product offering
Product offeringCore offering
Bright Therapeutics develops and delivers condition-specific digital therapeutic apps — Recovery Record for eating disorders, MoodLinks for mood and anxiety, Recovery Path for substance use, and Nourishly and its specialized variants for nutrition, diabetes, and IBS — that enable clinicians to extend evidence-based care between therapy sessions through daily client check-ins, guided therapeutic tasks, and session-ready progress data. The platform is offered to individual clinicians, clinical groups, large health systems, and health plans with EMR integration and customizable enterprise deployments.
Product overview
Bright Therapeutics operates a multi-diagnostic digital therapeutics platform that delivers condition-specific apps extending mental health care between sessions. The core portfolio includes Recovery Record (eating disorders), MoodLinks (mood and anxiety disorders), Recovery Path (substance use disorders), and Nourishly with its specialized variants for diabetes management and IBS/FODMAP tracking. These apps are designed to integrate with clinical workflows, providing daily client engagement, evidence-based interventions, automated outcome collection, and session-ready progress data for clinicians. The platform serves over 2 million patients through partnerships with 1,000+ clinical groups and major health systems.
Differentiator
Problem solved
Functional benefit
Brands
- Recovery Record: Digital therapeutic application for eating disorders
- MoodLinks
- Recovery Path
- Nourishly
- Nourishly for Diabetes
- Fast FODMAP for IBS
Products and services
- Recovery Record Condition-specific digital therapeutic app for eating disorders that enables daily client check-ins, guided tasks, and supportive nudges between therapy sessions, with session-ready progress data for clinicians. Cited as the most comprehensive eating disorder treatment app in peer-reviewed literature.
- MoodLinks Condition-specific digital therapeutic app for mood and anxiety disorders that delivers evidence-based care between visits, keeping clients engaged and therapy on track through daily check-ins and clinical outcome tracking.
- Recovery Path Condition-specific digital therapeutic app for substance use disorders that supports evidence-based treatment through daily engagement and clinical outcome tracking between therapy sessions.
- Nourishly Nutrition and diet-focused app that supports dietary tracking and intervention as part of Bright's condition-matched digital therapeutics portfolio for clinicians.
- Nourishly for Diabetes Specialized version of Nourishly designed for diabetes management, integrating nutritional tracking with diabetes-specific dietary guidance.
- Fast FODMAP for IBS Specialized version of Nourishly focused on FODMAP diet tracking for irritable bowel syndrome (IBS) management.
Quantifiable outcome
- Clients attend 9 additional outpatient sessions over 6 months compared to treatment as usual
- +5 more outcomes
Companies that use Bright Therapeutics
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
Bright Therapeutics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature6 records
Bright Therapeutics partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Duke UniversitycoreDuke University is listed as a research partner collaborating with Bright on scientific evaluation and evidence generation. Bright's science division works with Duke researchers on clinical trials and peer-reviewed publications validating digital therapeutic efficacy for eating disorders, substance use, and mood/anxiety disorders.
- Stanford MedicinecoreStanford Medicine collaborates with Bright on research partnerships to advance knowledge about effective mental health treatments. Stanford researchers work with Bright's science division to evaluate digital therapeutic outcomes and generate peer-reviewed evidence.
- Kaiser PermanentecoreKaiser Permanente is both a research partner and a major customer of Bright. As a research partner, Kaiser collaborates on evaluating Bright's digital therapeutics and advancing the evidence base. As a customer, Bright products are used across Kaiser's integrated health system to extend mental health care between sessions.
- University of North Carolina (UNC)coreUNC researchers partner with Bright on scientific collaboration and evidence generation. UNC Health also serves as a customer, utilizing Bright products across its provider network. The partnership advances knowledge about effective mental health treatments through clinical research and real-world implementation.
- Technical University of Munich (TUM)minorTUM is listed as a research partner collaborating with Bright on scientific evaluation and evidence generation for digital therapeutics in behavioral health care.
- Nova Scotia HealthminorNova Scotia Health is listed as a research partner collaborating with Bright to advance knowledge about effective mental health treatments through independent research and health system partnerships.
- Electronic Medical Record (EMR) SystemscoreBright provides bespoke integrations with electronic medical record (EMR) systems and reporting platforms for enterprise health system clients. These integrations ensure seamless data flow between Bright's apps and existing clinical workflows, enabling clinicians to document directly into notes or export and upload PDFs to client charts. EMR integration is a key enterprise sales differentiator.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Bright Therapeutics competitors and assessment
Company assessmentBroad incumbents
- Spring Health: Mental health benefits platform combining therapy, coaching, and digital exercises for employer and payer customers. Competes with Bright for health plan and enterprise behavioral health budgets.
- Talkspace: Online therapy platform connecting users to licensed therapists via messaging and video, distributed through employer and health plan benefits. Competes with Bright for payer mental health budgets with a broader therapy-delivery model.
- Lyra Health: Mental health benefits platform for employers and health plans offering therapy, coaching, and digital tools. Competes with Bright for payer and enterprise contracts in the behavioral health benefits category.
- Headspace Health: Combined Headspace and Ginger mental health platform offering self-guided content, coaching, and therapy to payers and employers. Broad incumbent in the digital behavioral health space competing with Bright for payer contracts and member mindshare.
Emerging players
- Equip Health: Virtual eating disorder treatment program delivering family-based treatment to adolescents and adults, accepted by major health plans. Most direct competitor to Bright's Recovery Record for eating disorder treatment in the payer-distributed care model.
- Woebot Health: AI chatbot-based digital therapeutic for mood and anxiety symptoms, targeting payer and provider distribution. Comparable to Bright's MoodLinks product in modality and target conditions but uses AI conversational approach rather than clinician-delivered framework.
- Meru Health: Digital mental health program for depression, anxiety, and burnout combining therapist-led video sessions with app-based content. Comparable to Bright in evidence-based approach and employer/payer distribution.
Direct peers
- Pear Therapeutics: Pioneer in prescription digital therapeutics (reSET, reSET-O) for substance use disorder and other behavioral health conditions. Most direct historical peer to Bright in condition-specific DTx, though the company has undergone significant restructuring.
- Akili Interactive: Digital therapeutics company with FDA-cleared cognitive therapy products (EndeavorRx for ADHD). Comparable to Bright as a prescription-style digital therapeutic company targeting specific behavioral health conditions with clinical evidence.
- Big Health: Digital therapeutics company focused on evidence-based behavioral health interventions (e.g., Sleepio for insomnia, Daylight for anxiety). Closely comparable to Bright as a payer-distributed, clinically validated DTx platform serving mental health conditions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Bright Therapeutics social profiles
Digital presenceBright Therapeutics compliance and trust
Trust signalCompliance1 record
Bright Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bright Therapeutics leadership team
Management profileNumber of profiles
Profiles2 records
Bright Therapeutics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bright Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bright Therapeutics
What does Bright Therapeutics do?
Bright Therapeutics develops and delivers condition-specific digital therapeutic apps — Recovery Record for eating disorders, MoodLinks for mood and anxiety, Recovery Path for substance use, and Nourishly and its specialized variants for nutrition, diabetes, and IBS — that enable clinicians to extend evidence-based care between therapy sessions through daily client check-ins, guided therapeutic tasks, and session-ready progress data. The platform is offered to individual clinicians, clinical groups, large health systems, and health plans with EMR integration and customizable enterprise deployments.
Is Bright Therapeutics a public or private company?
Bright Therapeutics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bright Therapeutics founded?
Bright Therapeutics was founded in -1. It employs 1 to 10 people.
Where is Bright Therapeutics based?
Bright Therapeutics is headquartered in San Francisco, United States, in the North America region.
How does Bright Therapeutics make money?
Four revenue lines are on record. Individual Clinician Subscriptions are the primary driver. The others are group/Corporate Accounts, enterprise Health Plan Contracts and enterprise Branded Solutions.
Who are Bright Therapeutics's main competitors?
Broad incumbents on record are Spring Health, Talkspace, Lyra Health and Headspace Health. Emerging players are Equip Health, Woebot Health and Meru Health. Direct peers are Pear Therapeutics, Akili Interactive and Big Health.
Does Bright Therapeutics have an API?
No public API is recorded for Bright Therapeutics.
What industry is Bright Therapeutics in?
Bright Therapeutics's product category is Digital Therapeutics / Behavioral Health Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACAFAD, Behavioral Health & Substance Use Remote Monitoring. Its NAICS code is 62142 and its SIC code is 8090.